Stockscreener 앱 받기
1.92
1.54%
-0.03
전일 마감가:
$1.95
열려 있는:
$1.92
하루 거래량:
23,303
Relative Volume:
0.21
시가총액:
$75.95M
수익:
$63.15M
순이익/손실:
$-40.30M
주가수익비율:
-1.1497
EPS:
-1.67
순현금흐름:
$-44.47M
1주 성능:
-9.86%
1개월 성능:
+3.78%
6개월 성능:
-28.09%
1년 성능:
-57.33%
1일 변동 폭
$1.9006
$1.95
1주일 범위
$1.5977
$2.1859
52주 변동 폭
$0.8645
$4.65
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.92 | 77.13M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
TELA Bio to Announce Q2 2025 Results with Live Webcast and Corporate Update - MSN
What analysts say about TELA Bio Inc. stockExponentially increasing returns - Autocar Professional
What risks could impact TELA Bio Inc. stock performanceOutstanding capital returns - jammulinksnews.com
TELA Bio Inc. Stock Analysis and ForecastSky-high return potential - PrintWeekIndia
why tela bio inc. stock attracts strong analyst attentionWealth Building Stock Portfolio - Newser
What institutions are buying TELA Bio Inc. stock nowFree Stock Market Beginners Guide - jammulinksnews.com
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
TELA Bio Soft-Tissue Tech Showcase: Key Investor Presentation Coming August 13 at Canaccord Conference - Stock Titan
Is TELA Bio Inc. a good long term investmentMarket-leading growth rates - jammulinksnews.com
What drives TELA Bio Inc. stock priceDynamic profit expansion - jammulinksnews.com
TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Medical Tech Leader TELA Bio Sets Q2 Earnings Date: Key Financial Results Coming August 11 - Stock Titan
Will TELA Bio Inc. stock benefit from AI tech trendsShort Squeeze Radar - Newser
How TELA Bio Inc. stock performs during market volatilityFree Stock Market Group - beatles.ru
Why TELA Bio Inc. stock is on top investor watchlists3x Return Stock Radar - Newser
Further Upside For TELA Bio, Inc. (NASDAQ:TELA) Shares Could Introduce Price Risks After 32% Bounce - simplywall.st
Why TELA Bio Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tela Bio Inc 주식 (TELA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
1.27%
자본화:
|
볼륨(24시간):